Events2Join

Pre|existing and de novo humoral immunity to SARS|CoV ...


Humoral Responses and Serological Assays in SARS-CoV-2 ...

Pre-existing and de novo humoral immunity to SARS-CoV-2 in humans. bioRxiv ... pre-pandemic sera from individuals with recent seasonal coronavirus infection.

Preexisting and de novo humoral immunity to SARS-CoV-2 in humans

Using diverse assays for antibodies recognizing SARS-CoV-2 proteins, we detect preexisting humoral immunity. SARS-CoV-2 spike glycoprotein (S)-reactive ...

SARS-CoV-2 breakthrough infections enhance T cell response ...

45. Alsoussi, W.B. ∙ Malladi, S.K. ∙ Zhou, J.Q. ... SARS-CoV-2 Omicron boosting induces de novo B cell response in humans ... ∙ Grifoni, A. Pre-existing SARS ...

Pre-existing and de novo humoral immunity to SARS-CoV-2 in ...

Pre-existing and de novo humoral immunity to SARS-CoV-2 in humans. Biology · Immunology · Pathology. Show More. Authors. Kevin Ng,Nikhil ...

Humoral immunity to SARS-CoV-2 vaccination in haemodialysis ...

), and de novo T-cellular SARS-CoV-2 immune response measurements as ... Existing print subscribers · Request institutional access ...

COVID-19 and pre-existing immunity | The BMJ

... SARS-CoV-2 pandemic with some pre-existing immunity. This is true of ... Preexisting and de novo humoral immunity to SARS-CoV-2 in humans.

What evidence is there for pre-existing antibody responses to SARS ...

Pre-existing and de novo humoral immunity to SARS-CoV-2 in humans, bioRxiv. Journal Article: V. van der Hiede, June 2020. SARS-CoV-2 cross-reactivity in ...

What evidence is there for pre-existing antibody responses to SARS ...

Pre-existing and de novo humoral immunity to SARS-CoV-2 in humans, bioRxiv. Journal Article: V. van der Hiede, June 2020. SARS-CoV-2 cross-reactivity in ...

Preexisting and de novo humoral immunity to SARS-CoV-2 in humans

Antibodies predating infection Immunological memory after infection with seasonal human coronaviruses (hCoVs) may potentially contribute to cross-protection ...

Pre‐existing immunity to SARS‐CoV‐2 associates with strong T cell ...

However, the relationship between pre-existing immunity against SARS-CoV-2 and the inactivated-vaccine-induced immune response is still unknown.

Pre-existing cross-reactive neutralizing activity against SARS-CoV-2 ...

16. Ng, KW ∙ Faulkner, N ∙ Cornish, G ... Pre-existing and de novo humoral immunity to SARS-CoV-2 in humans. Science. 2020; 370:1339-1343.

Unravelling humoral immunity in SARS-CoV-2 - Sage Journals

and Kassiotis G., Preexisting and de novo humoral immunity to SARS-CoV-2 in humans, Science. ... and Wu G., Pre-existing humoral immunity to human common ...

Is preexisting immunity to seasonal coronaviruses limited to cross ...

A total of 2545 samples, including 90 pre ... Ng, KW ∙ Faulkner, N ∙ Cornish, GH ∙ et al. Preexisting and de novo humoral immunity to SARS-CoV-2 ...

Study Detail - ImmPort

SDY2660: Pre-existing humoral immunity to human common cold coronaviruses negatively impacts the protective SARS-CoV-2 antibody response, ...

Some People – Mainly Children – Have Pre-existing Coronavirus ...

... antibodies. Reference: “Pre-existing and de novo humoral immunity to SARS-CoV-2 in humans” by Kevin W. Ng, Nikhil Faulkner, Georgina H ...

Impaired humoral and cellular immunity after SARS-CoV-2 ... - JCI

... (pre and post vaccination) and/or spike protein–specific ELISA (pre vaccination). No de novo induction or increase of existing anti-HLA antibodies was ...

Pre‐existing immunity to SARS‐CoV‐2 associates with strong T cell ...

Conflictingly, in COVID-19 patients, pre-existing seasonal coronavirus-specific antibodies negatively correlated with the de novo induction of ...

effects of preexisting immunity during the COVID-19 pandemic

Evidence and implications of pre-existing humoral cross-reactive immunity to SARS-CoV-2. ... Preexisting and de novo humoral immunity to SARS-CoV- ...

Immunological imprinting shapes the specificity of human antibody ...

Enhanced SARS-CoV-2 humoral immunity following breakthrough infec- · tion builds ... SARS- · CoV-2 Omicron boosting induces de novo B cell response in humans.

Challenges and Prospects in Developing Future SARS-CoV-2 ...

The NAb response is a key determinant of immune protection from viral infection and severe disease (2). It has been noted that pre-existing NAbs are key ...